Vaxxinova® is committed to disease prevention in production animals. Vaxxinova aims to provide a complete set of vaccines and diagnostic services, supported by their global R&D network. Vaxxinova believes in ‘business without borders’ and long-term partnerships with veterinarians and animal health professionals. Vaxxinova works together in disease prevention and the production of animal performance improvement programs. Their technical teams are geared to advise you on their products and services.
Though Vaxxinova was officially named and founded in 2010, its predecessors have been in the production of animal vaccines and diagnostics business since the 1950s. Vaxxinova can rely on more than 6 decades of expertise in disease prevention for production animals and products and services are available in more than 60 countries.
Vaxxinovaaims at providing a full range of both autogenous (where allowed) and licensed vaccines (where registered) combined with high-level diagnostic services, supported by our strong R&D. Our focus is on production animals including poultry, aqua, cattle and swine.
Vaxxinova is part of the family-owned EW Group which is based in Germany and specializes in animal genetics, animal nutrition and animal health. The EW Group operates in over 100 countries and records consistent international growth. Its positive outlook and global orientation have led to an independent and significantly stable position in the market and a steady expansion.
To improve the range and choice for poultry farmers, we've consolidated 18 new products which have multiple functions and numerous benefits. Some of the major benefits of these products include feed efficiency, antibiotic-free production, food enrichment, mycotoxin management, etc.
We are honoured and proud to announce this new partnership, and with this, we hope to bring the best out of the poultry industry.